CapsoVision, Inc. Announces CE Mark for the Use of CapsoCam Plus Capsule Endoscopy System in Patients Ages 2 and Above
Award-winning technology provides 360º imaging, eliminates need for receiver equipment during examination
SARATOGA, Calif., Oct. 25, 2017 (GLOBE NEWSWIRE) -- Today Silicon Valley-based CapsoVision, Inc. announced CE Mark approval for their CapsoCam Plus® System in patients ages 2 and above. It is the only wire-free capsule endoscopy system on the market that provides a full 360° panoramic lateral image of the small bowel mucosa.
"Gastroenterologists and patients have told us that CapsoCam Plus provided them with comfort and convenience compared to other capsule endoscopy systems," CapsoVision President Johnny Wang said. "Since CapsoCam Plus does not require patients to wear a data recorder like with ordinary capsule endoscopes, these benefits are more pronounced for use with younger patients and their caregivers."
The incidence of Inflammatory Bowel Disease (IBD) in pediatric patients worldwide is on the rise, particularly in Europe. According to a recent report commissioned by United European Gastroenterology (UEG), childhood onset of IBD now accounts for 20-30% of all IBD cases.1 Capsule endoscopy is one of the tools that pediatric gastroenterologists use to identify abnormalities of the small bowel that may lead to an IBD diagnosis.
Dr. Salvatore Oliva, pediatric gastroenterologist at the Sapienza University of Rome, Italy, will discuss the use of CapsoCam Plus in patients ages 2 and above at the United European Gastroenterology Week (UEGW) in Barcelona on October 31, 2017 at the CapsoVision exhibit booth and at a Panel Presentation in the evening. More information can be found at CapsoVision.com/events.
About CapsoVision, Inc.
CapsoVision, Inc. is a medical device innovator located in Silicon Valley. A company with out-of-the-box thinking and enviable human capital, CapsoVision strives to empower physicians and patients with innovative technologies that will provide superior clinical outcomes and improve quality of life. CapsoVision is currently working in 70+ countries through strong distribution partners.
The innovations embedded in the CapsoCam Plus system are seen to enhance physician experience in observing and diagnosing small bowel abnormalities while providing unparalleled comfort, convenience, and freedom to patients. CapsoCam's cutting-edge 360° panoramic lateral view and wire-free technology are setting new standards in capsule endoscopy. For more information, visit CapsoVision.com.
Email: Kristin@klunkmillan.com1 Paediatric Digestive Health Across Europe: Early Nutrition, Liver Disease and Inflammatory Bowel Disease. United European Gastroenterology (UEG) EU Affairs. May 2016. https://www.ueg.eu/epaper/UEG_Paediatric_Digestive_Health_Report/index.html
Information om Nasdaq OMX
Følg pressemeddelelser fra Nasdaq OMX
Skrive dig op her og du vil løbende modtage pressemeddelelser på mail. Indtast din mail, klik på abonner og følg instruktionerne i den udsendte mail.
Flere pressemeddelelser fra Nasdaq OMX
VistaJet Ltd22.11.2017 11:40 | pressemeddelelse
VistaJet Partners With Christie's for the Global Tour of The Collection of Peggy and David Rockefeller
Nasdaq22.11.2017 10:03 | pressemeddelelse
Nasdaq to Deliver Blockchain e-Voting Solution to Strate
Oxford Immunotec21.11.2017 15:16 | pressemeddelelse
Oxford Immunotec to Present at the 29th Annual Piper Jaffray Healthcare Conference
Crown Bioscience Inc.21.11.2017 14:02 | pressemeddelelse
CrownBio's Translatable FATZO Model Utilized in Eli Lilly's Preclinical Type 2 Diabetes Research Programs
OmniComm Systems Inc.21.11.2017 14:02 | pressemeddelelse
OmniComm Systems Signs Letter of Intent to Acquire Certain Assets of Algorithm and its Subsidiary Algorics
Nasdaq21.11.2017 11:32 | pressemeddelelse
Port Moresby Stock Exchange (POMSoX) Launches New Nasdaq Trading System
I vores nyhedsrum kan du læse alle vores pressemeddelelser, tilgå materiale i form af billeder og dokumenter, og finde vores kontaktoplysninger.Besøg vores nyhedsrum